Seed Life Science Companies

TAVRA Biosciences is a biotech company that offers cGMP‑manufactured stem cell products for the treatment of inflammation and injuries.

Drug-Delivery Technology

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

Exobiosphere is a cutting-edge company operating at the intersection of space exploration and biotechnology.

Optic is an AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation.

Pre Clinical Stage Company working with Advanced Cell Therapies to cure incurable diseases using cells.

Everest Biolabs supplies exosome and EV isolation tools, ELISA kits, and instruments for research in biotech and academic labs.

Bringing Ultrasound to the mass market with AI

Enabling tomorrow's therapies manufacturing for today's patients, with sound

Swarm Oncology is a biotechnology company that develops novel T cell therapies for cancer patients.

Base Molecular Resonance Technologies develops detection systems based on quantum-level particle interaction.

Albupad uses cutting-edge, environmentally friendly technology to create novel materials made entirely of proteins.

Sophomer provides artificial polymers made to replace the bovine serum albumin that is used in immunological tests.

Soteri Skin is a clinically-tested eczema relief topical company

Fortuna is a biotechnology company that provides forecasting and screening technology solutions for non-invasive embryo trait assessment.

Known Medicine combines patient-specific 3D cell culture and AI to translate drugs to clinical success

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

Mito Robotics is a robotics company that offers AI-powered robotic scientists for wet lab automation.

Stratum Biosciences focuses on leveraging artificial intelligence alongside biomarker discovery to create new dermatological therapies.

Impulsonics uses acoustic waves to streamline biotech automation and create unique capabilities in cell and tissue engineering.

Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.

Origin is a biotech company that creates patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies.

Synthetic Sciences builds AI agents that automate research workflows, from literature review to experiments and papers.

Ritivel develops AI native regulatory workforce platform for regulatory and medical writing teams at life science companies.

Nexgen Forensic Sciences is a biotechnology company currently operating in stealth mode.